Anebulo Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 4/6
Anebulo Pharmaceuticals has a total shareholder equity of $5.0M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $6.0M and $1.0M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$5.15m |
| Equity | US$4.99m |
| Total liabilities | US$1.01m |
| Total assets | US$6.00m |
Recent financial health updates
Is Anebulo Pharmaceuticals (NASDAQ:ANEB) In A Good Position To Deliver On Growth Plans?
Feb 18
Is Anebulo Pharmaceuticals (NASDAQ:ANEB) In A Good Position To Invest In Growth?
Jul 03Companies Like Anebulo Pharmaceuticals (NASDAQ:ANEB) Are In A Position To Invest In Growth
Mar 07We Think Anebulo Pharmaceuticals (NASDAQ:ANEB) Can Afford To Drive Business Growth
Nov 19Here's Why We're Not Too Worried About Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn Situation
Jun 28Companies Like Anebulo Pharmaceuticals (NASDAQ:ANEB) Are In A Position To Invest In Growth
Mar 15Recent updates
Is Anebulo Pharmaceuticals (NASDAQ:ANEB) In A Good Position To Deliver On Growth Plans?
Feb 18Is Anebulo Pharmaceuticals (NASDAQ:ANEB) In A Good Position To Invest In Growth?
Jul 03Companies Like Anebulo Pharmaceuticals (NASDAQ:ANEB) Are In A Position To Invest In Growth
Mar 07We Think Anebulo Pharmaceuticals (NASDAQ:ANEB) Can Afford To Drive Business Growth
Nov 19Anebulo Pharmaceuticals to launch private investment in public equity financing
Sep 26Anebulo Pharmaceuticals GAAP EPS of -$0.10 misses by $0.03
Sep 09Here's Why We're Not Too Worried About Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn Situation
Jun 28Companies Like Anebulo Pharmaceuticals (NASDAQ:ANEB) Are In A Position To Invest In Growth
Mar 15Here's Why We're Not Too Worried About Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn Situation
Nov 04Anebulo Pharmaceuticals reports FQ3 results
Jun 21Financial Position Analysis
Short Term Liabilities: ANEB's short term assets ($5.4M) exceed its short term liabilities ($1.0M).
Long Term Liabilities: ANEB has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: ANEB is debt free.
Reducing Debt: ANEB had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ANEB has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: ANEB has less than a year of cash runway if free cash flow continues to reduce at historical rates of 31.4% each year